论文部分内容阅读
目的:观察特布他林联合盐酸氨溴索微量吸入治疗毛细支气管炎的临床疗效。方法:2010年8月～2011年8月114例毛细支气管炎患儿随机分为两组,对照组57例采用常规治疗,观察组57例在常规治疗基础上给予特布他林联合盐酸氨溴索微量吸入治疗,观察两组的临床疗效及临床症状的变化。结果:观察组的总有效率为89.5%,明显高于对照组的64.9%(P<0.05);观察组咳嗽、喘鸣音、湿啰音消失时间及住院天数明显短于对照组(P<0.05)。结论:特布他林联合盐酸氨溴索微量吸入治疗毛细支气管炎,能够明显提高临床疗效,改善患儿症状,值得临床推广应用。
Objective: To observe the clinical efficacy of terbutaline combined with ambroxol hydrochloride in the treatment of bronchiolitis. Methods: From August 2010 to August 2011, 114 children with bronchiolitis were randomly divided into two groups. 57 cases in the control group were treated by conventional therapy. In the observation group, 57 cases were given terbutaline combined with ambroxol hydrochloride Cable trace inhalation therapy was used to observe the clinical efficacy and clinical symptoms of the two groups. Results: The total effective rate of the observation group was 89.5%, which was significantly higher than that of the control group (64.9%, P <0.05). The cough, wheeze, disappearance time of the wet rales and hospital stay in the observation group were significantly shorter than those in the control group (P < 0.05). Conclusion: The combination of terbutaline and ambroxol hydrochloride in the treatment of bronchiolitis can significantly improve the clinical efficacy and improve the symptoms of children, which is worthy of clinical application.